Expertise in
10
conditions

Haiquan S. Chen

270 Dong An Rd, 
Shanghai, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
10
conditions
270 Dong An Rd, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Haiquan Chen practices in Shanghai, China. Chen is highly rated in 10 conditions, according to our data. Their top areas of expertise are Lung Adenocarcinoma, Lung Cancer, Squamous Cell Lung Carcinoma, Lymphadenectomy, and Endoscopy.

Their clinical research consists of co-authoring 401 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

270 Dong An Rd, Shanghai, 200032, China
Other Locations
130 Dong An Road, Shanghai, 200032, China
No.270, Dong An Road, Shanghai, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multicenter Randomized, Controlled Phase III Clinical Trial of Pembrolizumab Plus Paclitaxel and Cisplatin Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Esophageal Squamous Cell Carcinoma (KEYSTONE-002)
A Multicenter Randomized, Controlled Phase III Clinical Trial of Pembrolizumab Plus Paclitaxel and Cisplatin Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Esophageal Squamous Cell Carcinoma (KEYSTONE-002)
Enrollment Status: Recruiting
Publish Date: June 01, 2022
Intervention Type: Biological, Radiation, Drug
Study Drugs: Pembrolizumab, Paclitaxel, Cisplatin
Study Phase: Phase 3
Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma
Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma
Enrollment Status: Completed
Publish Date: July 20, 2023
Intervention Type: Drug
Study Drugs: Pemetrexed, Cisplatin
Study Phase: Phase 2
Is Bronchoscopy Necessary in the Preoperative Workup of Ground Glass Opacity Featured Lung Cancer?
Is Bronchoscopy Necessary in the Preoperative Workup of Ground Glass Opacity Featured Lung Cancer?
Enrollment Status: Completed
Publish Date: July 20, 2023
Intervention Type: Device
Study Phase: Not Applicable
The Utility of Positron Emission Tomography (PET) in Predicting Cervical Lymphatic Metastasis for Mid-lower Thoracic Esophageal Squamous Cell Carcinoma
The Utility of Positron Emission Tomography (PET) in Predicting Cervical Lymphatic Metastasis for Mid-lower Thoracic Esophageal Squamous Cell Carcinoma
Enrollment Status: Completed
Publish Date: July 13, 2023
Intervention Type: Diagnostic test
A Single-arm, Phase II Study of Preoperative Gefitinib for Stage II-IIIa NSCLC With Activating EGFR Mutation
A Single-arm, Phase II Study of Preoperative Gefitinib for Stage II-IIIa NSCLC With Activating EGFR Mutation
Enrollment Status: Completed
Publish Date: July 12, 2023
Intervention Type: Drug
Study Drug: Gefitinib
Study Phase: Phase 2
View 4 Less Clinical Trials

401 Total Publications

Author Correction: Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition.
Author Correction: Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition.
Journal: Nature communications
Published: September 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chen's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile